Genetic Networks LLC
Genetic Networks accelerates drug asset development through applied modular biology, utilizing its proprietary GeneScapeTM platform to identify optimal targets and compounds across various disease spaces. The company aims to enable faster, safer, and more cost-effective drug development and repurposing by integrating genome-wide functional assays for drugs and human genes.
Industries
Nr. of Employees
small (1-50)
Genetic Networks LLC
Products
Integrated genome-wide functional mapping platform
A platform combining genome-wide functional assays for drugs and for human genes/variants with proprietary analytics to generate multi-dimensional disease-drug maps for discovery and repurposing.
Integrated genome-wide functional mapping platform
A platform combining genome-wide functional assays for drugs and for human genes/variants with proprietary analytics to generate multi-dimensional disease-drug maps for discovery and repurposing.
Services
Applied modular biology platform access
Provision of genome-scale functional screening and analytics services to map relationships between genes, variants, and compounds for target identification and compound prioritization.
High-throughput screening and assay execution
Execution of automated, optimized robotic workflows for large-scale genetic and compound perturbation experiments.
Integrative analytics and module identification
Analytical interpretation of screening data to identify conserved modules and actionable target-compound intersections using proprietary analytics.
Applied modular biology platform access
Provision of genome-scale functional screening and analytics services to map relationships between genes, variants, and compounds for target identification and compound prioritization.
High-throughput screening and assay execution
Execution of automated, optimized robotic workflows for large-scale genetic and compound perturbation experiments.
Integrative analytics and module identification
Analytical interpretation of screening data to identify conserved modules and actionable target-compound intersections using proprietary analytics.
Expertise Areas
- Functional genomics
- Chemogenomics and compound screening
- High-throughput screening automation
- Integrative computational biology and analytics
Key Technologies
- Genome-wide genetic perturbation screens
- Functional genomics assays
- High-throughput robotic screening
- Integrative analytics for disease-drug mapping